Table 3. Estimated number and rate of cancers, CIN3 and cytological abnormalities in women under age 30 in and per cent prevented by vaccination (with and without cross-protection).

	Cancera	CIN3a		Cytological abnormalitiesb
Age group	20–29	20–24	25–29	20–24	25–29
Population at risk	3 095 000c	1 546 000c	1 549 000c	353 239d	414 892d
Annual number of cases	224	4,013	4,996	53 672	47 914
Rate	7.2/105	260/105	322/105	15.2%	11.2%
Per cent prevented in vaccinated women with no cross-protection	79.1%	63.5%		34%
Number prevented with 80% coverage	142	2039	2538	14 599	13 033
Per cent prevented in women vaccinated with cross-protection	80.4%	70%		26.3%
Number prevented with 80% coverage	144	2247	2798	11 164	9966

^aCancer Statistics Registrations 2003.

^bScreening Programme Statistical Bulletin 2002–2003.

^cResident population.

^dNumber with an adequate smear test.